Robin Jones
Impact in
- Gastroenterology top 0.1%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.1%
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 252
-
- Gastrointestinal Tumor Research and Treatment 68
- Co-authors
- Khin Thway (97 shared papers)Cyril Fisher (55 shared papers)Ian Robert Judson (37 shared papers)Paul H. Huang (65 shared papers)Jorge Sergio Reis-Filho (15 shared papers)Seth M. Pollack (41 shared papers)Ian E. Smith (11 shared papers)Jonathan Christopher Noujaim (23 shared papers)
- Journals
- Annals of Oncology (52 papers)Future Oncology (25 papers)European Journal of Cancer (23 papers)Cancers (18 papers)Clinical Cancer Research (16 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Robin Jones
505 papers receiving 21.8k citations
Robin Jones's Hit Papers
Peers
Comparison fields: 5 of 142
- Gastroenterology 2.2k
- Pulmonary and Respiratory Medicine 9.1k
- Rheumatology 2.2k
- Cancer Research 1.7k
- Oncology 2.5k
Countries citing papers authored by Robin Jones
This map shows the geographic impact of Robin Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Jones more than expected).
Fields of papers citing papers by Robin Jones
This network shows the impact of papers produced by Robin Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Jones. The network helps show where Robin Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 531 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 1096 |
| 2 | Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Hit paper breakdown → | 2021 | 702 |
| 3 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Hit paper breakdown → | 2015 | 681 |
| 4 | Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 603 |
| 5 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Hit paper breakdown → | 2016 | 490 |
| 6 | Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 438 |
| 7 | 2007 | 381 | |
| 8 | Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2021 | 374 |
| 9 | Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study Hit paper breakdown → | 2020 | 319 |
| 10 | The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients Hit paper breakdown → | 2020 | 317 |
| 11 | Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2021 | 313 |
| 12 | Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 299 |
| 13 | 2005 | 290 | |
| 14 | 2007 | 281 | |
| 15 | An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG) Hit paper breakdown → | 2017 | 277 |
| 16 | 2008 | 258 | |
| 17 | 2020 | 251 | |
| 18 | 2017 | 243 | |
| 19 | 2017 | 241 | |
| 20 | Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial Hit paper breakdown → | 2020 | 241 |
About Robin Jones
Robin Jones is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Rheumatology, Oncology and Cancer Research, having authored 531 papers that have together received 22.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (252 papers), Gastrointestinal Tumor Research and Treatment (68 papers), Soft tissue tumor case studies (32 papers), Vascular Tumors and Angiosarcomas (21 papers), Breast Cancer Treatment Studies (20 papers), Chemotherapy-induced cardiotoxicity and mitigation (14 papers), Bone Tumor Diagnosis and Treatments (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Gastroenterology (2.2k citations), Pulmonary and Respiratory Medicine (9.1k citations), Rheumatology (2.2k citations), Cancer Research (1.7k citations) and Oncology (2.5k citations). Robin Jones has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Khin Thway, Cyril Fisher, Ian Robert Judson, Paul H. Huang, Jorge Sergio Reis-Filho, Seth M. Pollack, Ian E. Smith, Jonathan Christopher Noujaim, Omar Al‐Muderis and Anastasia Constantinidou. Their work appears in journals such as Annals of Oncology, Future Oncology, European Journal of Cancer, Cancers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.